Ann: Letter to Shareholders-AHZ.AX, page-2

ADMEDUS SET TO LAUNCH VASCULAR PRODUCT  Admedus to enter new revenue vertical with vascular product to be launched in November 2016  Vascular repair market worth circa USD$500 million per annum  Manufacturing and supply facilities implemented and ready for product launch  Cardiocel® brand awareness and established relationships to assist with marketing and penetration of the vascular product  Recently received 8 year Cardiocel® data confirms lack of calcification and remodeling capabilities giving patients and surgeons both near and longer-term benefits in repairing vascular defects